http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2297536-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34c531b0dce54fb192c75fd1f4f8d473 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 |
| filingDate | 2004-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fabf1d0065a2d4fdd5283f4f6bda2cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a30553f3801003efe58c1ad7bff5385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99b77794bf9877c56d8ee9629c291715 |
| publicationDate | 2008-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2297536-T3 |
| titleOfInvention | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RENAL DYSFUNCTIONS. |
| abstract | Use of a compound of general formula I: wherein R 1 means a phenyl-C 1-4 alkyl group which may be optionally substituted on the phenyl ring by C 1-4 alkyl, C 1-4 alkoxy or halogen, or by a naphthyl group -C1-4 alkyl, R2 means hydrogen or a group that forms a bi-volatile ester, and R3 means hydrogen or a group that forms a bi-volatile group, in which a group that forms a bi-volatile ester is independently selected in each case from a group C1-C4 alkyl; a phenyl or phenyl-C1-C4 alkyl group, particularly phenyl, benzyl or indanyl, which is optionally substituted on the phenyl ring by C1-C4 alkyl or by a C1-C4 alkylene chain attached to two adjacent carbon atoms, or a dioxolanylmethyl group, particularly (2,2-dimethyl-1,3-dioxolan-4-yl) methyl, which is optionally substituted on the dioxolane ring by C1-C4 alkyl, or a C2-C6-yloxymethyl alkane group optionally substituted on the oxymethyl group by C1-C4 alkyl; and / or a physiologically acceptable salt of the acids of formula I, and / or their physiologically acceptable solvate for the manufacture of a pharmaceutical composition for the treatment and / or prophylaxis of nephropathy comprising the excretion of proteinuria, urinary albumin and / or renal scarring in a human patient. |
| priorityDate | 2003-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 147.